{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:39:04Z","timestamp":1776440344864,"version":"3.51.2"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bursa Uludag University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein-associated disease (MOGAD) are autoimmune disorders frequently accompanied by chronic, often neuropathic, pain, which significantly impacts the quality of life, sleep, and mental health. This study evaluated the incidence and characteristics of neuropathic pain in 106 patients with NMOSD or MOGAD and assessed its effects on mental health, sleep quality, and overall quality of life. Using clinical evaluation and MRI findings to localize lesions, pain classification revealed that chronic pain was more common in NMOSD patients (78.4%) than in MOGAD patients (52.7%), with a significant impact on both groups. Patients with MOGAD who experienced neuropathic pain reported notably poorer sleep quality and higher anxiety and depression levels. Pain severity was strongly associated with spinal cord lesion length and thoracic location, particularly in MOGAD patients. Current treatments provide insufficient pain relief, highlighting the need for more effective management strategies. This study emphasized that neuropathic pain substantially diminishes both physical and mental well-being in NMOSD and MOGAD patients, highlighting the importance of personalized pain management approaches to improve quality of life and mental health in these populations.<\/jats:p>","DOI":"10.1007\/s10072-025-08277-6","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T20:58:29Z","timestamp":1749243509000},"page":"4555-4567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Characteristics of pain in patients with NMOSD and MOGAD: impact on mental health, sleep and quality of life"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0264-7284","authenticated-orcid":false,"given":"Emine Rabia","family":"Koc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Furkan","family":"Saridas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Fatih","family":"Yetkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuray","family":"Bilge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasemin","family":"Dinc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emel Oguz","family":"Akarsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarra Elhamida","family":"Lazrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanja","family":"Gluscevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulkadir","family":"Tunc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meral","family":"Seferoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caner","family":"Baydar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Ozhan","family":"S\u0131vac\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. Faruk","family":"Turan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guven","family":"Ozkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,7]]},"reference":[{"key":"8277_CR1","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1007\/s00415-023-11634-0","volume":"270","author":"S Jarius","year":"2023","unstructured":"Jarius S, Aktas O, Ayzenberg I et al (2023) Update on the diagnosis and treatment of neuromyelits Optica spectrum disorders (NMOSD)\u2013 revised recommendations of the neuromyelitis Optica study group (NEMOS). Part I: diagnosis and differential diagnosis. J Neurol 270:3341\u20133368. https:\/\/doi.org\/10.1007\/s00415-023-11634-0","journal-title":"J Neurol"},{"key":"8277_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R et al (2023) Diagnosis of Myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol 22:268\u2013282. https:\/\/doi.org\/10.1016\/S1474-4422(22)00431-8","journal-title":"Lancet Neurol"},{"key":"8277_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3988\/jcn.2023.0328","volume":"20","author":"H Ju","year":"2024","unstructured":"Ju H, Chung YH, Kwon S et al (2024) Usefulness of the MFIS-K, FSS, and FACIT-F fatigue scales in Korean patients with MS, NMOSD, and MOGAD. J Clin Neurol 20:431\u2013438. https:\/\/doi.org\/10.3988\/jcn.2023.0328","journal-title":"J Clin Neurol"},{"key":"8277_CR4","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3389\/fneur.2020.00778","volume":"11","author":"S Asseyer","year":"2020","unstructured":"Asseyer S, Cooper G, Paul F (2020) Pain in NMOSD and MOGAD: A systematic literature review of pathophysiology, symptoms, and current treatment strategies. Front Neurol 11:778. https:\/\/doi.org\/10.3389\/fneur.2020.00778","journal-title":"Front Neurol"},{"key":"8277_CR5","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.pmn.2019.03.003","volume":"20","author":"MA Mealy","year":"2019","unstructured":"Mealy MA, Kozachik SL, Levy M (2019) Review of treatment for central spinal neuropathic pain and its effect on quality of life: implications for neuromyelitis Optica spectrum disorder. Pain Manag Nurs 20:580\u2013591. https:\/\/doi.org\/10.1016\/j.pmn.2019.03.003","journal-title":"Pain Manag Nurs"},{"key":"8277_CR6","doi-asserted-by":"publisher","first-page":"102542","DOI":"10.1016\/j.msard.2020.102542","volume":"46","author":"W Huang","year":"2020","unstructured":"Huang W, ZhangBao J, Chang X et al (2020) Neuromyelitis Optica spectrum disorder in china: quality of life and medical care experience. Mult Scler Relat Disord 46:102542. https:\/\/doi.org\/10.1016\/j.msard.2020.102542","journal-title":"Mult Scler Relat Disord"},{"key":"8277_CR7","doi-asserted-by":"publisher","first-page":"104192","DOI":"10.1016\/j.msard.2022.104192","volume":"68","author":"H Xue","year":"2022","unstructured":"Xue H, Yang W, Zhao Y et al (2022) Pain in neuromyelitis optic spectrum disorder. Mult Scler Relat Disord 68:104192. https:\/\/doi.org\/10.1016\/j.msard.2022.104192","journal-title":"Mult Scler Relat Disord"},{"key":"8277_CR8","doi-asserted-by":"publisher","first-page":"104213","DOI":"10.1016\/j.msard.2022.104213","volume":"68","author":"X Zhang","year":"2022","unstructured":"Zhang X, Pei L, Xu Y et al (2022) Factors correlated with neuropathic pain in patients with neuromyelitis Optica spectrum disorder. Mult Scler Relat Disord 68:104213. https:\/\/doi.org\/10.1016\/j.msard.2022.104213","journal-title":"Mult Scler Relat Disord"},{"key":"8277_CR9","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000507","volume":"157","author":"E Kosek","year":"2016","unstructured":"Kosek E, Cohen M, Baron R et al (2016) Do we need a third mechanistic descriptor for chronic pain states? Pain 157:1382\u20131386. https:\/\/doi.org\/10.1097\/j.pain.0000000000000507","journal-title":"Pain"},{"key":"8277_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12883-022-02841-9","volume":"22","author":"X Li","year":"2022","unstructured":"Li X, Xu H, Zheng Z et al (2022) The risk factors of neuropathic pain in neuromyelitis Optica spectrum disorder: a retrospective case-cohort study. BMC Neurol 22:304. https:\/\/doi.org\/10.1186\/s12883-022-02841-9","journal-title":"BMC Neurol"},{"key":"8277_CR11","doi-asserted-by":"publisher","first-page":"205521731879668","DOI":"10.1177\/2055217318796684","volume":"4","author":"S Asseyer","year":"2018","unstructured":"Asseyer S, Schmidt F, Chien C et al (2018) Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis Optica spectrum disorders. Mult Scler J Exp Transl Clin 4:2055217318796684. https:\/\/doi.org\/10.1177\/2055217318796684","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"8277_CR12","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/ejp.1608","volume":"24","author":"F Valerio","year":"2020","unstructured":"Valerio F, Apostolos-Pereira SL, Sato DK et al (2020) Characterization of pain syndromes in patients with neuromyelitis Optica. Eur J Pain 24:1548\u20131568. https:\/\/doi.org\/10.1002\/ejp.1608","journal-title":"Eur J Pain"},{"key":"8277_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis Optica spectrum disorders. Neurology 85:177\u2013189. https:\/\/doi.org\/10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"key":"8277_CR14","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1097\/j.pain.0000000000000492","volume":"157","author":"NB Finnerup","year":"2016","unstructured":"Finnerup NB, Haroutounian S, Kamerman P et al (2016) Neuropathic pain: an updated grading system for research and clinical practice. Pain 157:1599\u20131606. https:\/\/doi.org\/10.1097\/j.pain.0000000000000492","journal-title":"Pain"},{"key":"8277_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jpain.2004.11.007","volume":"6","author":"MI Bennett","year":"2005","unstructured":"Bennett MI, Smith BH, Torrance N, Potter J (2005) The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain 6:149\u2013158. https:\/\/doi.org\/10.1016\/j.jpain.2004.11.007","journal-title":"J Pain"},{"key":"8277_CR16","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/j.1526-4637.2010.00837.x","volume":"11","author":"R Koc","year":"2010","unstructured":"Koc R, Erdemoglu AK (2010) Validity and reliability of the Turkish Self-administered Leeds assessment of neuropathic symptoms and signs (S-LANSS) questionnaire. Pain Med 11:1107\u20131114. https:\/\/doi.org\/10.1111\/j.1526-4637.2010.00837.x","journal-title":"Pain Med"},{"key":"8277_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/bja\/aen103","volume":"101","author":"H Breivik","year":"2008","unstructured":"Breivik H, Borchgrevink PC, Allen SM et al (2008) Assessment of pain. Br J Anaesth 101:17\u201324. https:\/\/doi.org\/10.1093\/bja\/aen103","journal-title":"Br J Anaesth"},{"key":"8277_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF, Monk TH et al (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193\u2013213. https:\/\/doi.org\/10.1016\/0165-1781(89)90047-4","journal-title":"Psychiatry Res"},{"key":"8277_CR19","unstructured":"A\u011farg\u00fcn MYKHAO (1996) Pittsburgh Uyku kalitesi indeksi\u2019nin ge\u00e7erli\u011fi ve g\u00fcvenirli\u011fi. Turk Psikiyatri Derg 107\u2013111"},{"key":"8277_CR20","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.2147\/NDT.S184260","volume":"14","author":"JL Pais-Ribeiro","year":"2018","unstructured":"Pais-Ribeiro JL, Martins da Silva A, Vilhena E et al (2018) The hospital anxiety and depression scale, in patients with multiple sclerosis. Neuropsychiatr Dis Treat 14:3193\u20133197. https:\/\/doi.org\/10.2147\/NDT.S184260","journal-title":"Neuropsychiatr Dis Treat"},{"key":"8277_CR21","doi-asserted-by":"publisher","first-page":"105648","DOI":"10.1016\/j.msard.2024.105648","volume":"87","author":"CA Young","year":"2024","unstructured":"Young CA, Langdon D, Rog D et al (2024) Prevalence, treatment and correlates of depression in multiple sclerosis. Mult Scler Relat Disord 87:105648. https:\/\/doi.org\/10.1016\/j.msard.2024.105648","journal-title":"Mult Scler Relat Disord"},{"key":"8277_CR22","doi-asserted-by":"publisher","first-page":"794353","DOI":"10.3389\/fpsyg.2021.794353","volume":"12","author":"A Jerkovi\u0107","year":"2021","unstructured":"Jerkovi\u0107 A, Prorokovi\u0107 A, Matijaca M et al (2021) Psychometric properties of the HADS measure of anxiety and depression among multiple sclerosis patients in Croatia. Front Psychol 12:794353. https:\/\/doi.org\/10.3389\/fpsyg.2021.794353","journal-title":"Front Psychol"},{"key":"8277_CR23","first-page":"280","volume":"8","author":"Aydemir Omer","year":"1997","unstructured":"Aydemir Omer (1997) Validity and reliability of Turkish version of hospital anxiety and depression scale. T\u00fcrk Psikiyatri Dergisi 8:280\u2013287","journal-title":"T\u00fcrk Psikiyatri Dergisi"},{"key":"8277_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473\u2013483","journal-title":"Med Care"},{"key":"8277_CR25","first-page":"102","volume":"12","author":"H Ko\u00e7yi\u011fit","year":"1999","unstructured":"Ko\u00e7yi\u011fit H, A\u00d6, \u00d6N ve MA (1999) K\u0131sa form-36 (KF36)\u2019n\u0131n T\u00fcrk\u00e7e Versiyonunun g\u00fcvenirlili\u011fi ve ge\u00e7erlili\u011fi. \u0130la\u00e7 Ve Tedavi Dergisi\u0130la\u00e7 Ve Tedavi Dergisi 12:102\u2013106","journal-title":"\u0130la\u00e7 Ve Tedavi Dergisi\u0130la\u00e7 Ve Tedavi Dergisi"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08277-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08277-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08277-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T18:23:07Z","timestamp":1757182987000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08277-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["8277"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08277-6","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,7]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this paper was updated to present the correct affiliations of all the authors.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from Bursa Uludag University Faculty of Medicine Ethics Committee (No: 2024-13\/7), and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The author(s) declare that there are no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}